Eugenodilol

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameEugenodilol
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptor alpha-1 antagonistsBeta-1 adrenergic receptor antagonistsBeta-2 adrenergic receptor agonists +[5] 
TargetsAdrenergic receptors alpha-1Beta-1 adrenergic receptorBeta-2 adrenergic receptor +[4] 
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive Companies +[1]  N/A
Active IndicationsN/A
Inactive IndicationsHeart Failure

Other Information

ATC CodeN/A
Related LinksN/A